Your browser doesn't support javascript.
loading
Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia.
Tiong, Ing S; Dillon, Richard; Ivey, Adam; Kuzich, James A; Thiagarajah, Nisha; Sharplin, Kirsty M; Kok, Chung Hoow; Tedjaseputra, Aditya; Rowland, James P; Grove, Carolyn S; Abro, Emad; Shortt, Jake; Hiwase, Devendra K; Bajel, Ashish; Potter, Nicola E; Smith, Matthew L; Hemmaway, Claire J; Thomas, Abin; Gilkes, Amanda F; Russell, Nigel H; Wei, Andrew H.
Afiliação
  • Tiong IS; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.
  • Dillon R; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Ivey A; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.
  • Kuzich JA; Guy's Hospital, London, United Kingdom.
  • Thiagarajah N; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.
  • Sharplin KM; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
  • Kok CH; Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, VIC, Australia.
  • Tedjaseputra A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Rowland JP; Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Grove CS; Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Abro E; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
  • Shortt J; Monash Health, Melbourne, VIC, Australia.
  • Hiwase DK; Princess Alexandra Hospital, Woolloongabba, QLD, Australia.
  • Bajel A; Department of Haematology, Sir Charles Gairdner Hospital and PathWest, Perth, WA, Australia.
  • Potter NE; Princess Alexandra Hospital, Woolloongabba, QLD, Australia.
  • Smith ML; Monash Health, Melbourne, VIC, Australia.
  • Hemmaway CJ; School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
  • Thomas A; Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Gilkes AF; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Russell NH; Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Wei AH; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.
Blood Adv ; 5(23): 5107-5111, 2021 12 14.
Article em En | MEDLINE | ID: mdl-34555849
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article